跳至主要内容
临床试验/ACTRN12608000058370
ACTRN12608000058370已完成不适用

For patients undergoing Computed Tomography (CT) Enteroclysis, self administered methoxyflurane via the Penthrox® inhaler may be better than placebo at improving patient tolerance of the procedure

Dr Alan Moss, Principal Investigator, Penthrox for CTE trial0 个研究点目标入组 60 人开始时间: 2008年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Referred for CT enteroclysis
  • Age 16 years or older
  • Able to give written informed consent themselves

排除标准

  • Known pre-existing renal or hepatic impairment: serum creatinine = 1.5 x upper limit of normal range (ULNR) or bilirubin = 2 x upper limit of normal range (ULNR).
  • Concomitant use of any of the following medications: tetracyclines, gentamicin, kanamycin, colistin, polymyxin b, cephaloridine or amphotericin b.
  • Personal or familial hypersensitivity to fluorinated anaesthetics.
  • Personal or familial malignant hyperthermia.
  • Pre-medication with anxiolytic eg. midazolam, diazepam.
  • Pre-medication with breakthrough dose of analgesic eg. paracetamol plus codeine or oxycodone.
  • Hypotension pre-procedure: systolic blood pressure <90 mmHg.
  • Bradycardia pre-procedure: heart rate <50 bpm.
  • Poor oxygen saturation pre-procedure: O2 saturation <90%.
  • Pregnancy: currently pregnant or attempting to become pregnant.
  • Lactation: currently breastfeeding.

研究者

发起方
Dr Alan Moss, Principal Investigator, Penthrox for CTE trial

相似试验